RESUMEN
Several authors have studied the release profile of drugs incorporated in different devices. However, to the best of our knowledge, although many studies have been done on the release of tetracycline, in these release devices, no study has investigated if the released compound is actually the tetracycline, or, instead, a degraded product. This approach is exploited here. In this work, we analyse the influence of two drying methods on the tetracycline delivery behaviour of synthesised glasses using the sol-gel process. We compare the drying methods results using both theoretical models and practical essays, and analyse the chemical characteristic of the released product in order to verify if it remains tetracycline. Samples were freeze-dried or dried in an oven at 37°C and characterised by several methods such as Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), thermogravimetric analysis (TG), differential thermogravimetric analysis (DTG), differential thermal analyses (DTA) and gas adsorption analysis (BET). The released concentration of tetracycline hydrochloride was studied as a function of time, and it was measured by ultraviolet spectrophotometry in the tetracycline wavelength. The drug delivery profiles were reasonably consistent with a diffusion model analysis. In addition, we observed higher release rates for the freeze-dried compared to those dried in an oven at 37°C. This higher release can be attributed to larger pore size for the freeze-dried sample systems with tetracycline, which promoted more water penetration, improving the drug diffusion. The analysis of the solution obtained in the release tests using high-performance liquid chromatography- mass spectrometry (HPLC-MS) confirmed that tetracycline was being released.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Liberación de Fármacos , Tetraciclinas/síntesis química , Antibacterianos/administración & dosificación , Antibacterianos/síntesis química , Antibacterianos/farmacocinética , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/síntesis química , Preparaciones de Acción Retardada/farmacocinética , Difusión , Composición de Medicamentos/métodos , Liofilización/métodos , Espectroscopía Infrarroja por Transformada de Fourier/métodos , Tetraciclinas/administración & dosificación , Tetraciclinas/farmacocinéticaRESUMEN
The combination of magnetic hyperthermia therapy with the controlled release of chemotherapeutic agents in tumors may be an efficient therapeutic with few side effects because the bioavailability, tolerance and amount of the drug can be optimized. Here, we prepared magnetoliposomes consisting of magnetite nanoparticle cores and the anticancer drug gemcitabine encapsulated by a phospholipid bilayer. The potential of these magnetoliposomes for controlled drug release and cancer treatment via hyperthermic behavior was investigated. The magnetic nanoparticle encapsulation efficiency was dependent on the initial amount of magnetite nanoparticles present at the encapsulation stage; the best formulation was 66%. We chose this formulation to characterize the physicochemical properties of the magnetoliposomes and to encapsulate gemcitabine. The mean particle size and distribution were determined by dynamic light scattering (DLS), and the zeta potential was measured. The magnetoliposome formulations all had acceptable characteristics for systemic administration, with a mean size of approximately 150 nm and a polydispersity index <0.2. The magnetoliposomes were stable in aqueous suspension for at least one week, as determined by DLS. Temperature increases due to the dissipation energy of magnetoliposome suspensions subjected to an applied alternating magnetic field (AMF) were measured at different magnetic field intensities, and the values were appropriated for cancer treatments. The drug release profile at 37 °C showed that 17% of the gemcitabine was released after 72 h. Drug release from magnetoliposomes exposed to an AMF for 5 min reached 70%.
Asunto(s)
Antimetabolitos Antineoplásicos/farmacología , Preparaciones de Acción Retardada/química , Desoxicitidina/análogos & derivados , Liposomas/química , Nanopartículas de Magnetita/química , Animales , Antimetabolitos Antineoplásicos/metabolismo , Supervivencia Celular/efectos de los fármacos , Preparaciones de Acción Retardada/farmacología , Desoxicitidina/metabolismo , Desoxicitidina/farmacología , Composición de Medicamentos , Liberación de Fármacos , Estabilidad de Medicamentos , Óxido Ferrosoférrico/química , Hipertermia Inducida/métodos , Luz , Liposomas/farmacología , Campos Magnéticos , Nanopartículas de Magnetita/ultraestructura , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/efectos de los fármacos , Tamaño de la Partícula , Fotoquimioterapia/métodos , Cultivo Primario de Células , Ratas , Ratas Endogámicas Lew , GemcitabinaRESUMEN
BACKGROUND: Dengue is a major public health problem worldwide, especially in the tropical and subtropical regions of the world. Infection with a single Dengue virus (DENV) serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients experiencing secondary infection with a different serotype progresses to the severe form of the disease, dengue hemorrhagic fever/dengue shock syndrome. Currently, there are no licensed vaccines or antiviral drugs to prevent or treat dengue infections. Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines. FINDINGS: Here, we used a murine model to evaluate the IgG production after administration of inactivated DENV corresponding to all four serotypes adsorbed to bovine serum albumin nanoparticles. This formulation induced a production of anti-DENV IgG antibodies (p < 0.001). However, plaque reduction neutralization assays with the four DENV serotypes revealed that these antibodies have no neutralizing activity in the dilutions tested. CONCLUSIONS: Our results show that while the nanoparticle system induces humoral responses against DENV, further investigation with different DENV antigens will be required to improve immunogenicity, epitope specicity, and functional activity to make this platform a viable option for DENV vaccines.
Asunto(s)
Anticuerpos Antivirales/biosíntesis , Virus del Dengue/inmunología , Nanopartículas , Animales , Virus del Dengue/crecimiento & desarrollo , Ratones , Microscopía Electrónica de Rastreo , Pruebas de Neutralización , Ensayo de Placa ViralRESUMEN
Cancer-Associated Fibroblasts (CAFs) contribute to tumour progression and have received significant attention as a therapeutic target. These cells produce growth factors, cytokines and chemokines, stimulating cancer cell proliferation and inhibiting their apoptosis. Recent advances in drug delivery have demonstrated a significant promise of iron oxide nanoparticles in clinics as theranostic agents, mainly due to their magnetic properties. Here, we designed superparamagnetic iron oxide nanoparticles (SPIONs) to induce apoptosis of human fibroblasts. SPIONs were synthesized via co-precipitation method and coated with sodium citrate (SPION_Cit). We assessed the intracellular uptake of SPIONs by human fibroblast cells, as well as their cytotoxicity and ability to induce thermal effects under the magnetic field. The efficiency and time of nanoparticle internalization were assessed by Prussian Blue staining, flow cytometry and transmission electron microscopy. SPIONs_Cit were detected in the cytoplasm of human fibroblasts 15 min after in vitro exposure, entering into cells mainly via endocytosis. Analyses through Cell Titer Blue assay, AnnexinV-fluorescein isothiocyanate (FITC) and propidium iodide (PI) cellular staining demonstrated that concentrations below 8 × 10-2 mg/mL of SPIONs_Cit did not alter cell viability of human fibroblast. Furthermore, it was also demonstrated that SPIONs_Cit associated with alternating current magnetic field were able to induce hyperthermia and human fibroblast cell death in vitro, mainly through apoptosis (83.5%), activating caspase 8 (extrinsic apoptotic via) after a short exposure period. Collectively these findings suggest that our nanoplatform is biocompatible and can be used for therapeutic purposes in human biological systems, such as inducing apoptosis of CAFs.
Asunto(s)
Apoptosis/efectos de los fármacos , Compuestos Férricos/farmacología , Fibroblastos/efectos de los fármacos , Nanopartículas Magnéticas de Óxido de Hierro/administración & dosificación , Fibroblastos Asociados al Cáncer/efectos de los fármacos , Muerte Celular/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Ácido Cítrico/química , Endocitosis , Compuestos Férricos/química , Citometría de Flujo , Humanos , Hipertermia Inducida , Nanopartículas Magnéticas de Óxido de Hierro/química , Microscopía Electrónica de Transmisión , Neoplasias/metabolismo , Neoplasias/patologíaRESUMEN
It is well known that nano-sized materials often present chemical, electronic, magnetic, and mechanical properties that are potentially interesting for many technological applications comparatively to their corresponding bulk properties. This paper describes the main differences in magnetic properties among nanomagnetite powders prepared by three methods: (I) reduction-precipitation of ferric chloride by reaction with Na2SO3; (II) reduction of hematite with coal, and (III) reduction of hematite with hydrogen gas. The obtained materials were characterized by powder X-ray diffraction (XRD), saturation magnetization measurements, and Mössbauer spectroscopy. Saturation magnetization values varied from 60 to 86 J T(-1)kg(-1). XRD and Mössbauer spectroscopy results at 298 K showed the clear effect of the preparation routes on the crystallographic structure and crystallite size of the magnetic species. Magnetite was formed in varying proportions in all samples, with crystallite sizes estimated by Scherrer formula of about 10, 26, and 33 nm for samples prepared by methods (I), (II), and (III), respectively. The Mössbauer spectrum of the sample prepared by method (I) consisted of broad lines and hyperfine field for magnetite lower than that typically reported for the bulk material.